Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
Cardiovascular Diabetology, 04/25/2011
Kuznik A et al. – The proportion of diabetic individuals taking lipid– and blood pressure(BP)–lowering agents has increased significantly in recent years. However, while there has been a significant improvement in low–density lipoprotein cholesterol(LDL–C) goal attainment, nearly one–half of all U.S. adults with diabetes are not at recommended LDL–C or BP treatment goals.
9,167 men and nonpregnant women aged [greater than or equal to]20 years were identified from the fasting subsample of the 1999–2008 National Health and Nutritional Examination Survey
Diabetes was identified in 1,214 participants by self report, self–reported use of insulin or oral medications for diabetes, or fasting glucose [greater than or equal to]6.99 mmol/L (126 mg/dL)
The prevalence of diagnosed or undiagnosed diabetes increased significantly over the past decade, from 7.4% in 1999–2000 to 11.9% in 2007–2008 (P=0.0007)
During this period, the use of lipid–lowering agents by participants with diabetes increased from 19.5% to 42.2% (P<0.0001), and the proportion at LDL–C goal increased from 29.7% to 54.4% (P<0.0001)
Although there was a significant increase in antihypertensive medication use (from 35.4% to 58.9%; P<0.0001), there was no significant change in the proportion of participants at BP goal (from 47.6% to 55.1%; P=0.1333) or prevalence of hypertension (from 66.6% to 74.2%; P=0.3724)
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.